Expert Opinion On Drug Safety

所属栏目:SCI期刊 热度:200

Expert Opinion On Drug Safety

Expert Opinion On Drug Safety

期刊周期:Bimonthly
研究方向:医学
影响因子:3.22
通讯地址:INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
官网:http://www.tandfonline.com/loi/ieds20#.V48bfkz9cSQ
投稿地址:https://mc.manuscriptcentral.com/eods
审稿速度:较慢,6-12周

  中文简介

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1474-0338.Expert Opinion on Drug Safety (EODS) is a new bimonthly journal providing comprehensive coverage of the safety of new and established drug therapies. With the ever-expanding armamentarium of drugs and drug therapies available, rational pharmacotherapy today is a complex art. At the forefront of this problem is the need to provide the most effective drug regimen whilst avoiding any adverse drug reactions. From the first point of concept to establishment on the market, monitoring the safety of a drug is critical to a drug's development and commercialisation. With pharmaceutical pipelines burgeoning and further growth of medicines likely in the post-genomic era, there is rapid expansion in the quantity of primary data relating to drug safety. Through systematic review and evaluation, Expert Opinion on Drug Safety seeks to unravel this vast amount of information and provide clear and informed guides to this increasingly important area.

  英文简介

由Informa Pharmaceutical Science出版(原Ashley Publications)。ISSN: 1474 - 0338。《药物安全专家意见》(EODS)是一份新出版的双月刊,全面报道新药物和现有药物治疗的安全性。随着药物和药物治疗手段的不断发展,今天的合理药物治疗是一门复杂的艺术。这个问题的首要问题是需要提供最有效的药物治疗方案,同时避免任何药物不良反应。从概念的第一点到市场的建立,监测药物的安全性对药物的开发和商业化至关重要。在后基因组时代,随着药物管道的蓬勃发展和药物的进一步发展,与药物安全性有关的原始数据量迅速增加。通过系统的审查和评估,药品安全专家意见力求揭示这一庞大的信息,并为这一日益重要的领域提供明确和知情的指导。

  近年期刊自引率趋势图

  JCR分区

JCR分区等级 JCR所属学科 分区 影响因子
Q2 PHARMACOLOGY & PHARMACY Q2 4.011

  近年期刊影响因子趋势图

  CiteScore数值

CiteScore SJR SNIP 学科类别 分区 排名 百分位
6.10 0.882 1.171 大类:Medicine 小类:Pharmacology (medical) Q1 54 / 255

79%

  相关医学SCI期刊推荐

SCI服务

搜论文知识网的海量职称论文范文仅供广大读者免费阅读使用! 冀ICP备15021333号-3